Found: 6
Select item for more details and to access through your institution.
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy?
- Published in:
- Radiation Oncology, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13014-023-02251-2
- By:
- Publication type:
- Article
Personalised support of brain tumour patients during radiotherapy based on psychological profile and quality of life.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 8, p. 4555, doi. 10.1007/s00520-021-06000-7
- By:
- Publication type:
- Article
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20417-y
- By:
- Publication type:
- Article
The Italian version of the Pediatric Quality of Life Inventory™ (PEDSQL™) 3.0 healthcare satisfaction hematology/oncology module: reliability and validity in radiation oncology.
- Published in:
- Health & Quality of Life Outcomes, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12955-023-02149-3
- By:
- Publication type:
- Article
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 10, p. 2367, doi. 10.1007/s00277-020-04220-1
- By:
- Publication type:
- Article
The Multidimensional Assessment for Pediatric Patients in Radiotherapy (M.A.P.-RT) Tool for Customized Treatment Preparation: RADAR Project.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.621690
- By:
- Publication type:
- Article